Stock XXY CROSS COUNTRY HEALTHCARE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Cross Country Healthcare, Inc. Deutsche Boerse AG

Equities

XXY

US2274831047

Real-time Estimate Tradegate
Other stock markets
 02:04:13 2024-07-01 EDT 		5-day change 1st Jan Change
12.9 EUR +2.38% Intraday chart for Cross Country Healthcare, Inc. -5.26% -38.24%
05-06 Barrington Cuts Price Target on Cross Country Healthcare to $21 From $24, Maintains Outperform Rating MT
05-01 (CCRN) CROSS COUNTRY HEALTHCARE Sees Q2 EPS Range $0.10 - $0.20 MT

Strengths

  • The stock, which is currently worth 2024 to 0.3 times its sales, is clearly overvalued in comparison with peers.
  • The company appears to be poorly valued given its net asset value.
  • The company has a low valuation given the cash flows generated by its activity.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
  • The company's earnings growth outlook lacks momentum and is a weakness.
  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company does not generate enough profits, which is an alarming weak point.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Sector: Employment Services

1st Jan change Capi. Investor Rating ESG Refinitiv
CROSS COUNTRY HEALTHCARE, INC. Stock Cross Country Healthcare, Inc.
-38.24% 481M -
RANDSTAD N.V. Stock Randstad N.V.
-25.37% 8.04B
A-
ROBERT HALF INTERNATIONAL, INC Stock Robert Half International, Inc
-27.23% 6.6B
A-
MANPOWERGROUP INC. Stock ManpowerGroup Inc.
-12.17% 3.33B
A-
PERSOL HOLDINGS CO.,LTD. Stock Persol Holdings Co.,Ltd.
-6.20% 3.16B
C+
STERLING CHECK CORP. Stock Sterling Check Corp.
+6.32% 1.45B -
FESCO GROUP CO., LTD. Stock FESCO Group Co., Ltd.
-12.91% 1.27B -
SHANGHAI FOREIGN SERVICE HOLDING GROUP CO., LTD. Stock Shanghai Foreign Service Holding Group Co., Ltd.
-16.46% 1.26B -
KFORCE INC. Stock Kforce Inc.
-8.04% 1.16B
B-
SYNERGIE SE Stock Synergie SE
-8.24% 814M
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. CCRN Stock
  4. XXY Stock
  5. Ratings Cross Country Healthcare, Inc.